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Abstract
Introduction Aging is associated with a decline in cardiac
contractility and altered immune function. The aim of this study
was to determine whether aging alters endotoxin-induced
myocardial dysfunction.
Methods Senescent (24 month) and young adult (3 month)
male Wistar rats were treated with intravenous
lipopolysaccharide (LPS) (0.5 mg/kg (senescent and young
rats) or 5 mg/kg (young rats only)), or saline (senescent and
young control groups). Twelve hours after injection, cardiac
contractility (isolated perfused hearts), myofilament Ca2+
sensitivity (skinned fibers), left ventricular nitric oxide end-
oxidation products (NOx and NO2) and markers of oxidative
stress (thiobarbituric acid reactive species (TBARS) and
antioxidant enzymes) were investigated.
Results LPS (0.5 mg/kg) administration resulted in decreased
contractility in senescent rats (left ventricular developed
pressure (LVDP), 25 ± 4 vs 53 ± 4 mmHg/g heart weight in
control; P < 0.05) of amplitude similar to that in young rats with
LPS 5 mg/kg (LVDP, 48 ± 7 vs 100 ± 7 mmHg/g heart weight
in control; P < 0.05). In contrast to young LPS rats (0.5 and 5
mg/kg LPS), myofilament Ca2+  sensitivity was unaltered in
senescent LPS hearts. Myocardial NOx and NO2  were
increased in a similar fashion by LPS in young (both LPS doses)
and senescent rats. TBARS and antioxidant enzyme activities
were unaltered by sepsis whatever the age of animals.
Conclusion Low dose of LPS induced a severe myocardial
dysfunction in senescent rats. Ca2+  myofilament
responsiveness, which is typically reduced in myocardium of
young adult septic rats, however, was unaltered in senescent
rats. If these results are confirmed in in vivo conditions, they may
provide a cellular explanation for the divergent reports on
ventricular diastolic function in septic shock. In addition, Ca2+-
sensitizing agents may not be as effective in aged subjects as in
younger subjects.
Introduction
Impairment in cardiac function is one of the most recognized
organ dysfunctions in sepsis. Although the mechanism of myo-
cardial dysfunction is complex and remains incompletely
defined, increasing experimental evidence suggests that the
main subcellular mechanisms include decreased cardiac myo-
filament responsiveness, nitric oxide (NO)-peroxynitrite activa-
tion, and inhibition of mitochondrial oxidative phosphorylation
[1]. Surprisingly, while sepsis predominantly affects older per-
sons, and although this segment of population will increase
significantly in intensive care units over the coming years, only
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few experimental data on septic organ dysfunction in the aged
animal are available.
A senescent heart is characterized by a progressive decline in
contractile function, with slowing of twitch contraction, altered
Ca2+ handling kinetics, and impaired β-adrenergic modulation
of contractility [2-4]. Aging is also characterized by an altered
immune function and response to stress, including endotoxic
challenge [5]. Septic myocardial dysfunction may thus be
altered with aging in its severity, mediators, and/or main cellu-
lar mechanisms.
We have previously shown in young adult animal models of
endotoxemia that troponin I phosphorylation decreases myofil-
ament Ca2+ sensitivity and may contribute to the depression of
cardiac contractility [6,7]. The role of this alteration in the
pathophysiology of septic myocardial depression has recently
been confirmed in transgenic mice with cardiac-specific
expression of slow skeletal troponin I (which lacks the protein
kinase A phosphorylation sites) [8]. Reduced myofilament
Ca2+ sensitivity is also proposed as a cellular basis for the ven-
tricular dilation described in fluid-resuscitated septic patients
[9]. Therapeutic implications have recently been shown with
the beneficial use of levosimendan, a new 'Ca2+-sensitizing'
agent, in both endotoxemic animals [10] and septic shock
patients with left ventricular dysfunction [11].
Whether these experimental findings and their clinical implica-
tions are relevant to septic dysfunction in the senescent heart
is not known. To test this hypothesis, we established a model
of myocardial dysfunction in senescent endotoxemic rats
derived from a model of myocardial dysfunction during mild
endotoxemia in the young adult rat [7,12], and we assessed
cardiac contractility and myofilament Ca2+ responsiveness in
both young adult rats and senescent rats. In order to charac-
terize more precisely the impact of aging on septic cardiac
dysfunction, we also investigated several of its putative medi-
ators (NO pathway and oxidative stress) in hearts from endo-
toxemic animals.
Materials and methods
Animal models
All procedures conformed to the framework of the French leg-
islation that controls animal experimentation. Experiments
were carried out in young (3 months old) and senescent (24
months old) male Wistar rats (Charles River Laboratories,
L'Arbresle, France). Twenty-four months old is the age in Wis-
tar rats at which natural mortality (since birth) is 50%, a rate
that defines senescence.
Young adult rats were given an intravenous injection of lipopol-
ysaccharide (LPS) endotoxin (Escherichia coli 0111:B4 from
a single batch (number 31K4121), 5 mg/kg; Sigma-Aldrich,
Saint Quentin Fallavier, France) or of saline in the dorsal penile
vein under brief halothane anesthesia. Animals were thereafter
conscious and unresuscitated until the time of killing 12 hours
later. Following LPS injection, animals exhibited prostration
and moderate body weight loss. Mortality 12 hours after LPS
injection was less than 10%, as previously reported [7,12].
In preliminary experiments, doses of LPS used in young adults
(5 mg/kg) induced 100% mortality in senescent rats within the
first 12 hours of endotoxemia. Mortality at 12 hours was still
greater than 50% in senescent rats injected with doses of 1–
2 mg/kg. In contrast, the injection of 0.5 mg/kg LPS induced
a model of endotoxemic senescent rats where external
appearance, weight loss, and mortality were very similar to that
observed in young rats receiving 5 mg/kg, and this smaller
dose was thus chosen for the study.
To allow interpretation of the results, another group of young
adult rats received a dose of 0.5 mg/kg. In summary, five
groups of animals were thus studied: two groups of senescent
rats (control or LPS 0.5 mg/kg) and three groups of young
adult rats (control, LPS 0.5 mg/kg, or LPS 5 mg/kg). The same
volume was injected in all groups.
Isolated Langendorff-perfused heart
Twelve hours after LPS or saline injection, the rats were anes-
thetized with an intraperitoneal injection of thiopenthal sodium
(Nesdonal, Specia; Rhône-Poulenc, Paris, France). The hearts
were then rapidly excised and perfused according to the Lan-
gendorff method at a perfusion pressure of 75 mmHg. The
perfusate was a Krebs–Henseleit solution containing NaCl
118 mmol/l, NaHCO3 25 mmol/l, KCl 4.75 mmol/l, KH2PO4
1.18 mmol/l, MgSO4 1.17 mmol/l, CaCl2 1.25 mmol/l, glucose
10 mmol/l (pH 7.4, 37°C), and was bubbled constantly with
95% O2/5% CO2, as previously reported [7].
The left ventricular pressure was measured using a compliant
water-filled balloon, connected to a pressure transducer (Sen-
soNor SP 844; Capto, Horten, Norway) via a rigid polyethyl-
ene tube introduced into the left ventricle through the mitral
valve, and was recorded on a Power Lab acquisition system
(ADInstruments Pty Ltd, Castle Hill, Australia). The hearts
were paced at 300 beats/minute via electrodes placed on the
left atrial wall and connected to a stimulator (6002 model; Har-
vard Biosciences, Les Ulis, France). The collapsed balloon
was filled with saline to obtain a left ventricular end diastolic
pressure of 5 mmHg. After 15–20 minutes of equilibration, the
left ventricular developed pressure (LVDP), the peak of the
positive and negative pressure derivatives (respectively, dP/
dtmax  and -dP/dtmax) as well as the coronary flow were
recorded.
Skinned myocardial fibers
After excision of the heart, ventricular fiber bundles (approxi-
mately 200 µm in diameter) were dissected from left ventricu-
lar papillary muscles in a relaxing solution free of Ca2+ (see
composition below). Fibers were then incubated for one hourAvailable online http://ccforum.com/content/10/4/R124
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in a relaxing solution containing 1% Triton X-100 to solubilize
the membranes without affecting the contractile proteins, as
previously reported [13]. After the skinning procedure, one
bundle was mounted between a fixed end and a force trans-
ducer (FT-03C model; Grass Instruments, Quincy, MA, USA)
in a 0.8 ml chamber filled with the relaxing solution, adjusted
to slack length, stretched by 20%, and subjected to an activa-
tion/relaxation cycle. The muscle contraction was amplified on
a differential amplifier (Biological Amplifier 120; BioScience,
Washington, DC, USA) connected to a recorder (TA240
model; Gould Electronic, Cleveland, OH, USA). The length
and diameter of the muscles were measured by use of a grat-
icule in the dissecting microscope. The sarcomere length in
our setup was verified by a calibrated micrometer for several
bundles from adult and senescent rats under a 400× Zeiss
lens. Values ranged between 2.2 and 2.4 µm for all bundles
tested. For all the following described experiments, the length
of the fibers was kept constant to avoid sarcomere length-
dependent changes in Ca2+ sensitivity. All experiments were
performed at constant temperature (22°C).
The relaxing solution contained 3-(N-morpholino)-propane sul-
fonic acid 10 mmol/l, potassium propionate 170 mmol/l, mag-
nesium acetate 2.5 mmol/l, and K2-EGTA 5 mmol/l. Activating
solutions had the same composition as the relaxing solution
except that Ca2+-EGTA was substituted for K2-EGTA at vari-
ous ratios. The concentrations of the different components in
the solutions were calculated using program 3 of Fabiato and
Fabiato [14] to keep the ionic strength at 200 mM. Solution
also contained ATP (2.5 mmol/l) and phosphocreatine (10
mmol/l), and the pH was 7.00 ± 0.01. Free Ca2+ concentra-
tions of activating solutions ranged from pCa 6.2 ([Ca2+] =
0.63 µM) to pCa 4.6 ([Ca2+] = 25.0 µM, maximally activating
solution), where pCa = -log10[Ca2+]. All chemicals were
obtained from Sigma-Aldrich.
For each skinned cardiac bundle, the resting tension was first
recorded. Measurements of active developed tension were
then performed after stepwise exposure of the fibers from pCa
6.2 to pCa 4.6. To quantify myofilament Ca2+ sensitivity, inter-
mediate tensions were expressed as a percentage of the max-
imal tension obtained at pCa 4.6. Data were fitted using a
nonlinear fit of the Hill equation (EnzFitter 1.05; Biosoft, Cam-
bridge, UK). The slope coefficient (Hill coefficient) as well as
the pCa value for half-maximal tension (pCa50) were calcu-
lated for each bundle.
Myocardial nitric oxide content
The NO content in the left ventricle was determined as the NO
end-oxidation products (nitrate and nitrite) (NOx). The NOx
measurements were performed using the Griess reaction as
previously reported [15]. Briefly, the nitrate present in samples
was stoichiometrically reduced to nitrite in the presence of
reduced nicotinamide adenine dinucleotide and nitrate reduct-
ase, for 15 minutes at 37°C. Total nitrite was mixed with sulfa-
nilamide and N-(1-naphtyl)ethylenediamine dihydrochloride at
room temperature for 10 minutes to generate a red–violet
diazo dye that was measured on the basis of its absorbance at
550 nm. The nitrite concentration was determined from a
standard curve generated using potassium nitrite. Results
were normalized for protein concentration.
Lipid peroxidation
The level of lipid peroxidation, a marker of oxidative injury, was
assessed via thiobarbituric acid reactive substances (TBARS)
formation during an acid-heating reaction, as previously
described [16]. Briefly, left ventricular tissue was homoge-
nized in phosphate buffer at 4°C. A 100 µl homogenate was
pipetted into a test tube, followed by addition of 100 µl of
8.1% sodium dodecylsulfate, 750 µl of 0.8% thiobarbituric
acid, 750 µl of 20% acetic acid (pH 3.5), and the volume was
made up to 2.0 ml with distilled water. To minimize peroxida-
tion during the assay procedure, 50 µl of 0.8% butyl-hydroxy-
toluene solution in acetic acid was added to the thiobarbituric
acid reagent mixture. Tube contents were then boiled at 95°C
for one hour. Following cooling to room temperature and cen-
trifugation (4,000 rpm for 10 minutes), the absorbance of the
supernatant was read spectrophotometrically at 532 nm. The
amount of TBARS was calculated from a standard curve using
malondialdehyde as a standard. Results were expressed in
malondialdehyde equivalents per milligram of protein.
Antioxidant enzyme activities
Superoxide dismutase (SOD), catalase (CAT), and glutathione
peroxidase (GPX) activities were measured in myocardial tis-
sue as previously reported [17,18]. Briefly, the SOD activity
was assayed by measuring the inhibition of oxidation of 2-(4-
idiophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium to yield a
chromophore with maximal absorbance at 505 nm, using a
commercially available kit (Ransod; Randox, San Diego, CA,
USA). The CAT activity was determined after sonication of the
tested sample in phosphate buffer, as the rate of decrease in
hydrogen peroxide absorbance at 240 nm, according to Aebi
[17]. The GPX activity was measured as described previously
[18] using a colorimetric assay kit (Cellular GPX Assay kit;
Calbiochem, San Diego, CA, USA), where GPX activity is
derived from quantification of NADPH oxidation (absorbance
at 340 nm) in a solution also containing reduced glutathione,
glutathione reductase, and tert-butyl hydroperoxide to initiate
the reaction. All results were normalized for protein
concentration.
Statistical analysis
All values are expressed as the mean ± standard error of the
mean. Comparisons between control and LPS groups were
made using an unpaired Student's t test or, when more than
two groups were compared, an analysis of variance and the
Fisher's PLSD post hoc test. Where needed, the interaction
between age and LPS was tested using a two-way analysis of
variance. All P  values were two-tailed, and P  < 0.05 wasCritical Care    Vol 10 No 4    Rozenberg et al.
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required to reject the null hypothesis. Statistical analysis was
performed with Statview 5.0 software (SAS Institute Inc.,
Cary, NC, USA).
Results
Changes in the body weight and main organ weight in
response to 12-hour endotoxemia in each age group are sum-
marized in Table 1. In senescent rats, LPS induced a body
weight loss and an increase in heart weight and lung weight
similar to those observed in both groups of young rats treated
with LPS. In addition, a significant liver weight loss was
present in young rats after LPS 5 mg/kg only, and was present
in senescent rats (Table 1). As expected from preliminary
experiments and previous studies, mortality was lower than
10% in all LPS groups.
Isolated Langendorff-perfused hearts
LPS 5 mg/kg in young rats induced a contractile dysfunction,
as reported by an approximately 50% decrease of LVDP and
other indices of myocardial function (Table 2). The reduction
in LVDP observed in young rats injected with 0.5 mg/kg sug-
gested that depression of contractility may be dose depend-
ent, although the difference between the two LPS-injected
young groups did not reach statistical significance (Table 2).
In senescent hearts, left ventricular function was altered in
basal conditions. A marked depression, of a relative amplitude
similar to that recorded in young rats after LPS 5 mg/kg, was
observed in senescent rats after LPS 0.5 mg/kg (Table 2).
Two-way analysis, however, showed no significant interaction
between age and LPS 0.5 mg/kg. The effect of LPS 0.5 mg/
kg on the LVDP therefore did not differ according to age. Cor-
onary flow was not altered by endotoxemia, whatever the age
of the rats (Table 2).
Myofilament Ca2+ responsiveness in skinned fibers
Maximal Ca2+-activated tension was similar between endotox-
emic animals and their control groups (Table 3). In young rats,
LPS 5 mg/kg induced a decrease in myofilament Ca2+ sensi-
tivity (Figure 1a), as attested by a significant decrease in
pCa50 (0.14 pCa units) without significant change in the Hill
coefficient (Table 3). This desensitization was also present in
the LPS 0.5 mg/kg group (mean decrease in pCa50, 0.12 pCa
units; Figure 1a and Table 3). In contrast, skinned fibers from
senescent LPS rats exhibited no significant changes in pCa50
or in Hill coefficient values (Table 3 and Figure 1b) as com-
pared with fibers from control senescent rats. This suggested
that cardiac myofilament Ca2+ sensitivity was not altered dur-
ing endotoxemia in senescent rats.
Table 1
Main characteristics of young rats and senescent rats treated with lipopolysaccharide (LPS) or saline
Young rats (3 months old) Senescent rats (24 months old)
Control group (n = 9) LPS 0.5 mg/kg group (n = 12) LPS 5 mg/kg group (n = 9) Control group (n = 13) LPS 0.5 mg/kg group (n = 16)
Initial body weight (g) 315 ± 3 331 ± 8 331 ± 5 451 ± 26 459 ± 15
∆BW (g) -1 ± 1 -18 ± 2* -11 ± 3* -2 ± 2 -16 ± 2*
Liver (g) 12.1 ± 0.8 10.9 ± 0.4 10.1 ± 0.3* 10.9 ± 0.7 9.2 ± 0.4*
Lung (g) 1.30 ± 0.03 1.46 ± 0.04* 1.45 ± 0.03* 4.14 ± 0.47 6.07 ± 0.60*
Heart weight (g) 0.98 ± 0.02 1.09 ± 0.05* 1.10 ± 0.02* 1.34 ± 0.10 1.60 ± 0.10*
Left ventricular weight (g) 0.78 ± 0.02 0.83 ± 0.03 0.85 ± 0.02 1.00 ± 0.07 1.11 ± 0.06
Values are the mean ± standard error of the mean. ∆BW, body weight 12 hours after treatment - initial body weight. *P < 0.05 versus respective 
control (saline-injected) group.
Table 2
Effects of in vivo lipopolysaccharide (LPS) on isolated and perfused hearts of young rats and senescent rats
Young rats (3 months old) Senescent rats (24 months old)
Control group (n = 8) LPS 0.5 mg/kg group (n = 9) LPS 5 mg/kg group (n = 9) Control group (n = 11) LPS 0.5 mg/kg group (n = 13)
LVDP (mmHg/g HW) 100 ± 7 64 ± 6* 48 ± 7* 53 ± 4 25 ± 4*
dP/dtmax (mmHg/s/g HW) 2744 ± 186 1611 ± 138* 1216 ± 152* 1804 ± 260 893 ± 158*
-dP/dtmax (mmHg/s/g HW) -1863 ± 61 -1320 ± 116* -1058 ± 103* -919 ± 91 -480 ± 59*
Coronary flow (ml/minute/g HW) 14 ± 2 14 ± 1 13 ± 2 10 ± 1 12 ± 1
Values are the mean ± standard error of the mean. LVDP, left ventricular developed pressure; dP/dtmax, peak of the positive pressure derivative; -dP/
dtmax, peak of the negative pressure derivative. *P < 0.05 versus respective control (saline-injected) group.Available online http://ccforum.com/content/10/4/R124
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Inflammatory mediator: nitric oxide
Following LPS administration, the NOx and NO2 myocardial
content increased in a similar fashion in senescent rats and
young rats as compared with their respective controls (Figure
2).
Oxidative stress: TBARS and antioxidant enzyme 
activities
Dosages of TBARS in the left ventricle from young rats
showed that cardiac lipid peroxidation was not significantly
increased in our sublethal model of endotoxemia, whatever the
dose of LPS (5 mg/kg or 0.5 mg/kg) administered (Figure 3).
Similar results were observed in senescent rats (Figure 3). The
CAT, SOD, and GPX myocardial activities were not signifi-
cantly altered in any LPS group (Figure 4).
Discussion
The present study tested whether aging alters endotoxin-
induced myocardial dysfunction in a sublethal model of endo-
toxemia in rats. The main findings were the following: 12 hours
after LPS injection (0.5 mg/kg), a marked reduction in myocar-
dial contractility was observed in the isolated perfused senes-
cent heart; in contrast with septic cardiac dysfunction in young
rats, myofilament Ca2+ sensitivity of left ventricular skinned fib-
ers was not reduced in senescent rats; and NO production,
oxidative stress, and antioxidant enzymes activities were not
different between young adult and senescent LPS groups.
Thus, despite similar alterations in potential mediators, cellular
mechanisms responsible for this contractile dysfunction are
different between young adult and senescent rats. More
specifically, myofilament Ca2+ responsiveness remains unal-
tered in the senescent heart. This may have clinical implica-
tions for management of elderly septic patients.
Nonlethal models of endotoxemia have allowed characteriza-
tion of septic myocardial depression in young animals while
avoiding nonspecific effects of shock [7,12,19]. A reduction
by a factor 10 (endotoxin dose from 5 to 0.5 mg/kg) was nec-
essary to reach this objective in senescent rats. This is in
accordance with the few other available studies on sepsis in
aged animals [5,20,21]. Indeed, mice 24–25 months old have
Figure 1
Isometric tension–pCa relations Isometric tension–pCa relations. (a) Isometric tension–pCa relations 
obtained in Triton-skinned left ventricular fibers from young rats (3 
months old; control, n = 23 fibers; lipopolysaccharide (LPS) 0.5 mg/kg, 
n = 23; and LPS 5 mg/kg, n = 22) treated with LPS or saline (control). 
(b) Isometric tension–pCa relations in Triton-skinned left ventricular fib-
ers from senescent rats (24 months old; control, n = 22 fibers; LPS 0.5 
mg/kg, n = 20). Curves of fibers from LPS-treated (0.5 and 5 mg/kg) 
animals were shifted toward lower pCa values only in young rats, indi-
cating a decrease in Ca2+ sensitivity of the contractile proteins. Values 
are the mean ± standard error of the mean.
Figure 2
Left ventricular nitric oxide end-oxidation products Left ventricular nitric oxide end-oxidation products. Left ventricular nitric 
oxide end-oxidation products (nitrate + nitrite) (NOx) and NO2 contents 
from young rats (3 months old; control, n = 5; LPS 0.5 mg/kg, n = 7; 
LPS 5 mg/kg, n = 5) and senescent rats (24 months old; control, n = 
16; LPS 0.5 mg/kg, n = 14) treated with lipopolysaccharide (LPS) or 
saline (control). Values are the mean ± standard error of the mean. *P < 
0.05 versus control group.Critical Care    Vol 10 No 4    Rozenberg et al.
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been found to be 10–16 times more sensitive to LPS lethality
than young (2 months old) mice [22,23]. The death rate in
aged (24 months old) versus young (4 months old) mice has
been shown to be dramatically higher after LPS injection or
cecal ligation and puncture [21]. This reduction in LPS dose
allowed us to compare young rats and senescent rats for car-
diac contractile dysfunction of apparently similar severity.
Precise comparison of the amplitude of septic contractile
depression between young adult rats and old rats remains
speculative, however, as, in accordance with previous studies,
indices of contractility in basal conditions were different
between the two age groups [2,3]. In our experimental condi-
tions, however, the major contractile depression recorded fol-
lowing LPS in senescent rats versus young rats primarily
resulted from reduced performance in basal conditions rather
than a larger effect of endotoxemia in old animals. The
measurements performed in young rats injected with LPS 0.5
mg/kg show that there is no simple proportional relation
between the intensity of mechanical depression, putative
mediators such as NO production, and the LPS dose. More
importantly, they validate the main results of the study, since
they show that the absence of myofilament desensitization in
hearts from senescent rats could not be explained by the
reduced dose of LPS.
The precise mechanisms for age-dependent vulnerability of
the heart to endotoxemia and sepsis remain largely unknown.
This can be explained, however, at least in part by reduced
physiological reserves and an altered inflammatory response
to stress [20,22,24]. The latter may include cardiac NO pro-
duction. In senescent rats, cardiac constitutive nitric oxide syn-
thase (NOS) activity and cardiac endothelial NOS levels were
found higher than in young rats, suggesting that much of this
increased NOS activity in the aged heart took place in the
endothelium rather than in the myocyte [25,26]. It has also
been suggested that the inducible NOS/NO pathway may
contribute to ventricular dysfunction during the aging process
in mice [27], but these results have not been confirmed in rats
[26]. Only one study measured the inducible NOS protein
abundance and NOS activity after injection of a cocktail of
LPS and IFN-γ in rats, finding that induction of inducible NOS
Figure 3
Left ventricular thiobarbituric acid reactive substances content Left ventricular thiobarbituric acid reactive substances content. Left 
ventricular thiobarbituric acid reactive substances (TBARS) content 
from young rats (3 months old; control, n = 11; lipopolysaccharide 
(LPS) 0.5 mg/kg, n = 8; LPS 5 mg/kg, n = 16) and senescent rats (24 
months old; control, n = 8; LPS 0.5 mg/kg, n = 8) treated with LPS or 
saline (control). Results are expressed as malondialdehyde (MDA) 
equivalents per milligram of protein (see Materials and methods). The 
TBARS content was not significantly different in LPS animals versus 
control animals whatever the age and the LPS dose studied (0.5 or 5 
mg/kg in young rats). Values are the mean ± standard error of the 
mean.
Figure 4
Left ventricular superoxide dismutase activity, catalase activity, and glu- tathione peroxidase activity Left ventricular superoxide dismutase activity, catalase activity, and glu-
tathione peroxidase activity. (a) Left ventricular superoxide dismutase 
(SOD) activity in young rats (3 months old; control, n = 6; lipopolysac-
charide (LPS) 0.5 mg/kg, n = 7; LPS 5 mg/kg, n = 6) and senescent 
rats (24 months old; control, n = 8; LPS 0.5 mg/kg, n = 8) treated with 
LPS or saline (control). (b) Left ventricular catalase activity in young 
rats (control, n = 9; LPS 0.5 mg/kg, n = 8; LPS 5 mg/kg, n = 11) and 
senescent rats (control, n = 7; LPS 0.5 mg/kg, n = 7). (c) Left ventricu-
lar glutathione peroxidase (GPX) activity in young rats (control, n = 9; 
LPS 0.5 mg/kg, n = 8; LPS 5 mg/kg, n = 9) and senescent rats (con-
trol, n = 7; LPS 0.5 mg/kg, n = 7). Activities of the three antioxidant 
enzymes were unchanged during endotoxemia whatever the age and 
the LPS dose studied (0.5 or 5 mg/kg in young rats). Values are the 
mean ± standard error of the mean.Available online http://ccforum.com/content/10/4/R124
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expression and activity was greater in senescent hearts com-
pared with young hearts, while the Ca2+-dependent NOS
activity was unchanged [26]. Our observation that endotox-
emia resulted in an increased NOx accumulation in the myo-
cardium of young rats and of senescent rats is consistent with
these findings. Further study should precise the relation
between these observations and the depression of contractil-
ity in septic senescent animals.
Many studies have suggested that oxidative stress, resulting
from mitochondrial dysfunction, excessive reactive oxygen
species formation, and altered cellular antioxidant pathways,
plays an important role in the development of septic organ dys-
function [28-30]. Following intraperitoneal injection of LPS in
rats, the SOD activity and peroxynitrite (3-nitrotyrosine) were
elevated in the left ventricle, although they did not parallel the
time-course of decreased contractility [28]. In another study
using a model of cecal ligature and puncture in rats, mitochon-
drial dysfunction, an imbalance between SOD and CAT activ-
ities, and increased TBARS content have been reported in the
myocardium [30]. Moreover, in cells from the senescent heart
versus the young heart, an enhanced likelihood for generation
of reactive oxygen species during stress as well as an
increased susceptibility to undergo protein damage in
response to oxidative stress have been reported [5]. Our data
in young adult rats as well as senescent rats, however, show
that severe septic contractile cardiac dysfunction may occur in
the absence of reactive oxygen species-induced cellular
alterations in nonlethal endotoxemia. This apparent discrep-
ancy with previous literature can be explained by the results of
a recent study showing that oxidative damage, altered antioxi-
dant enzyme activities, and an early increase in TBARS occur
in the heart and other tissues essentially during lethal sepsis
[31].
Reduced myofilament Ca2+ sensitivity found in left ventricle tis-
sue from young rats in the present study confirms data previ-
ously reported in intact cardiomyocytes in rats and in skinned
cardiac fibers in rabbits [6,7,32,33]. Myofilament Ca2+ desen-
sitization during sepsis is related to an increase in
phosphorylation of troponin I at Ser 23/24 [7]. The difference
in pCa50 value found between control and LPS fibers in young
adult rats is likely to be biologically significant, as we previ-
ously showed that the endotoxemia-induced decrease in the
pCa50 value was as large as that obtained following ex vivo
incubation of control fibers with isoproterenol (a well estab-
lished β-adrenergic agonist that induces a protein kinase A
(PKA)-dependent decrease in Ca2+ sensitivity of contractile
proteins and, in turn, accelerates relaxation in in vivo condi-
tions) [9].
Phosphorylation of specific serine and threonine residues on
cardiac troponin I by several different protein kinases repre-
sents a major physiological mechanism for alteration of myofil-
ament properties [34]. The absence of reduction in
myofilament Ca2+  sensitivity found in skinned fibers from
senescent hearts thus suggests that protein kinase-depend-
ent phosphorylation of troponin I was attenuated in the septic
senescent heart. This difference cannot be attributed to the
lower LPS dose used in senescent rats since the same low
dose reduced Ca2+ sensitivity in hearts from young rats. A dif-
ferent timescale is also an unlikely explanation as the desensi-
tization has been reported as early as 4 hours after LPS
injection and was still present 30 hours later in young endotox-
emic animals [6,9,33]. The cAMP-dependent protein kinase
(PKA) activity has been found increased in the hearts of young
septic animals [35]. This suggests that the PKA pathway may
be involved in septic myofilament desensitization. Interestingly,
activation of the β-adrenergic–PKA–myofilament protein
phosphorylation pathway declines with aging [36]. This may
thus contribute to the difference observed in myofilament Ca2+
sensitivity between young hearts and senescent hearts during
endotoxemia in the present study. On the other hand, protein
phosphorylation via cGMP-dependent protein kinase (protein
kinase G), which includes troponin I, seems also decreased
during aging [37], thus providing another potential explanation
for our observations.
Our study has potential limitations. First, we used a rat model
of aging. Rodents differ from humans from a biological point of
view, especially concerning body growth. Only a few animal
models of aging, however, associate a short lifespan and the
Table 3
Effects of in vivo lipopolysaccharide (LPS) on left ventricular skinned fibers of young rats and senescent rats
Young rats (3 months old) Senescent rats (24 months old)
Control group (n = 4 rats, 
n = 23 fibers)
LPS 0.5 mg/kg group (n = 
4 rats, n = 23 fibers)
LPS 5 mg/kg group (n = 5 
rats, n = 22 fibers)
Control group (n = 4 rats, 
n = 22 fibers)
LPS 0.5 mg/kg group (n = 5 
rats, n = 20 fibers)
Resting tension (mN/mm2) 3.2 ± 0.5 3.4 ± 0.4 3.7 ± 0.6 6.6 ± 0.5 4.4 ± 0.4*
Maximal active tension (mN/
mm2)
47.4 ± 3.8 54.4 ± 3.3 51.5 ± 7.6 43.0 ± 3.2 41.8 ± 4.2
pCa50 (pCa units) 5.81 ± 0.04 5.69 ± 0.04* 5.67 ± 0.04* 5.58 ± 0.03 5.53 ± 0.03
Hill coefficient 1.60 ± 0.12 1.66 ± 0.11 1.58 ± 0.09 1.43 ± 0.09 1.57 ± 0.10
Values are the mean ± standard error of the mean. pCa50, Ca2+ concentration for half-maximal tension, expressed in pCa units (with pCa = -
log[Ca2+]). *P < 0.05 versus respective control (saline-injected) group.Critical Care    Vol 10 No 4    Rozenberg et al.
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control of environmental influences. For cardiovascular stud-
ies, the senescent rat is by far the most used animal model of
aging. Indeed, physiological changes as well as cellular
changes such as myocyte loss, hypertrophy of the remaining
myocytes and fibrosis, observed in the human heart during
aging, are also found in the senescent rat heart [4,36]. Sec-
ond, we used three month old rats as controls because at this
age septic cardiac dysfunction has been characterized in most
previous studies. Three months of age, however, represents
young adult rats that are not fully grown and developed. As a
result the age difference discussed may not be due to senes-
cence or aging but actually due to maturation. To demonstrate
changes due to aging, a mature adult group (aged 9–12
months) would be required. Third, the pertinence of acute
endotoxemia as a model for human sepsis has been ques-
tioned. The cellular and molecular mechanisms of cardiac dys-
function demonstrated in this model, however, have been
generally confirmed in more sophisticated models. Finally,
extensive characterization of the various potential mechanisms
of septic cardiac dysfunction in the senescent heart needs fur-
ther investigation. In addition, study of cardiovascular dysfunc-
tion in septic senescent animals is needed to appreciate the
relevance of the present results.
Our results may have clinical implications. First, reduced myo-
filament Ca2+ sensitivity has been proposed to constitute the
cellular basis of the acute ventricular dilation reported in septic
patients [9,38]. Indeed, a reduction in myofilament responsive-
ness is associated with increased length in single cardiac
myocytes and increased ventricular distensibility [34]. The
reality of this dilation during septic shock in humans, however,
has led to conflicting results [38,39]. Our results in aged ani-
mals offer a possible explanation at the cellular level for these
divergent observations. Second, our finding that a decrease in
myofilament responsiveness to Ca2+ is a determinant of intrin-
sic myocardial depression in septic shock suggested that
Ca2+-sensitizing agents may be appropriate treatment to
improve heart function in sepsis. Animal studies and, more
recently, human studies have begun to test this hypothesis
[10,11]. Our results in aged rats raise the possibility that these
agents might not be as effective in aged patients as in younger
patients.
Conclusion
Aging is associated with decline in cardiac contractility and
altered immune function. Septic myocardial dysfunction may
thus be altered with aging in its severity, mediators, and/or
main cellular mechanisms. This study demonstrated that a low
dose of LPS induced a severe myocardial dysfunction in
senescent rats. This was accompanied by an increased myo-
cardial NO production without evidence of oxidative stress,
similarly to cardiac dysfunction in young adult rats. Ca2+ myo-
filament responsiveness, however, which is typically reduced
in the myocardium of young septic rats, was unaltered in
senescent rats. If these results are confirmed in in vivo condi-
tions, they may provide a cellular explanation for the conflicting
results regarding the reality of ventricular distensibility during
septic shock. In addition, Ca2+-sensitizing agents may not be
as effective in aged patients as in younger patients.
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Key messages
•  Aging is associated with decline in cardiac contractility 
and altered immune function; in this study, a low dose of 
LPS induced a severe cardiac contractile depression in 
senescent rats.
•  Endotoxemia-induced myocardial dysfunction in both 
young rat and senescent rat groups was accompanied 
by an increased NO production without evidence of oxi-
dative stress.
• Ca2+ myofilament responsiveness, which is typically 
reduced in the myocardium of young adult septic rats, 
was unaltered in senescent rats.
•  If these results are confirmed in in vivo conditions, they 
may provide a cellular explanation for the divergent 
reports on ventricular diastolic function in septic shock. 
In addition, Ca2+-sensitizing agents may not be as effec-
tive in aged patients as in younger patients.Available online http://ccforum.com/content/10/4/R124
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